Adenosiinilla aloitettu kardioplegia sydämen suojana

Phase 1

• Conditions: Coronary artery disease, aortic stenosis; MedDRA version: 16.1Level: PTClassification code 10011078Term: Coronary artery diseaseSystem Organ Class: 10007541 - Cardiac disorders; MedDRA version: 16.1Level: PTClassification code 10002906Term: Aortic stenosisSystem Organ Class: 10047065 - Vascular disorders; Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]

• Registration Number: EUCTR2014-001382-26-FI
• Lead Sponsor: TAYS Sydänsairaala

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-04-14
• Last Update Posted: 8 June 2020

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

elective surgery for coronary artery disease or aortic valve stenosis
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 50

Exclusion Criteria

inability to comprehend the study protocol
emergent operation

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified